Teva's Cost-Cutting Plan Nets A Mizuho Upgrade By: Benzinga via Benzinga January 09, 2018 at 10:56 AM EST After a turbulent 2017, Mizuho analysts now see upside potential for Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA)'s ... Read More >> Related Stocks: Momenta Pharma Teva Pharmaceutical Industries ADR